MAPT and Mental deterioration: In ADNI MCI A+ T+ participants, neither CSF sTREM2 nor sTNFR2 levels predicted future cognitive decline on CDR-SB when taking into account CSF p-tau or t-tau levels (Figure 2, Table 6).